Detection/NN
of/IN
oestrogen/NN
receptor/NN
variants/NNS
in/IN
endometrium/NN
,/,
myometrium/NN
,/,
leiomyoma/NN
and/CC
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
:/:
comparison/NN
to/TO
variants/NNS
present/JJ
in/IN
breast/NN
cancer/NN
./.

Oestradiol/NN
has/VBZ
mitogenic/JJ
and/CC
regulatory/JJ
effects/NNS
on/IN
various/JJ
organs/NNS
and/CC
cells/NNS
,/,
mediated/VBN
mainly/RB
by/IN
its/PRP$
nuclear/JJ
receptor/NN
(/(
ER/NN
)/)
./.
=====
The/DT
presence/NN
of/IN
aberrant/JJ
ER/NN
forms/NNS
in/IN
Oestrogen-dependent/JJ
tumours/NNS
has/VBZ
been/VBN
discussed/VBN
in/IN
correlation/NN
with/IN
tumour/NN
progression/NN
./.
=====
ER/NN
variants/NNS
,/,
generated/VBN
by/IN
alternative/JJ
splicing/NN
,/,
have/VBP
been/VBN
detected/VBN
in/IN
human/JJ
breast/NN
cancer/NN
,/,
but/CC
also/RB
in/IN
normal/JJ
mammary/JJ
glands/NNS
,/,
therefore/RB
their/PRP$
role/NN
in/IN
tumorigenesis/NN
has/VBZ
been/VBN
questioned/VBN
./.
=====
We/PRP
have/VBP
investigated/VBN
,/,
by/IN
the/DT
use/NN
of/IN
the/DT
reverse/JJ
transcription/NN
polymerase/NN
chain/NN
reaction/NN
amplification/NN
technique/NN
,/,
the/DT
possible/JJ
existence/NN
of/IN
ER/NN
variants/NNS
in/IN
other/JJ
normal/JJ
oestrogen/NN
target/NN
organs/NNS
and/CC
cells/NNS
,/,
such/JJ
as/IN
uterus/NN
(/(
myometrium/NN
and/CC
endometrium/NN
)/)
,/,
in/IN
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
and/CC
in/IN
a/DT
benign/JJ
uterus/NN
tumour/NN
(/(
leiomyoma/NN
)/)
./.
=====
We/PRP
have/VBP
detected/VBN
variant/JJ
ER/NN
in/IN
these/DT
samples/NNS
and/CC
have/VBP
compared/VBN
the/DT
variant/JJ
profile/NN
to/TO
that/DT
observed/VBN
in/IN
breast/NN
cancer/NN
./.
=====
All/DT
tissues/NNS
and/CC
cells/NNS
studied/VBN
expressed/VBD
both/CC
wild-type/JJ
ER/NN
and/CC
variant/JJ
species/NNS
./.
=====
Variant/JJ
forms/NNS
encompassed/VBD
ER/NN
with/IN
deletions/NNS
of/IN
exons/NNS
2/CD
,/,
5/CD
and/CC
7/CD
./.
=====
Variants/NNS
with/IN
exon/NN
5/CD
deleted/VBN
were/VBD
detected/VBN
only/RB
in/IN
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
and/CC
in/IN
breast/NN
cancer/NN
./.
=====
Variants/NNS
with/IN
exons/NNS
2/CD
and/CC
7/CD
deleted/VBN
were/VBD
present/JJ
in/IN
all/DT
specimens/NNS
tested/VBN
./.
=====
These/DT
results/NNS
corroborate/VBP
previous/JJ
findings/NNS
that/IN
the/DT
presence/NN
of/IN
ER/NN
variants/NNS
is/VBZ
not/RB
a/DT
characteristic/NN
of/IN
breast/NN
cancer/NN
./.
=====
The/DT
physiological/JJ
significance/NN
and/CC
possible/JJ
clinical/JJ
relevance/NN
of/IN
the/DT
variant/JJ
ER/NN
forms/NNS
remain/VBP
to/TO
be/VB
elucidated/VBN
./.